Bartlett & Co Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.06M | Sell |
7,987
-174
| -2% | -$24.4K | 0.01% | 262 |
|
|
2025
Q4 | $1M | Buy |
8,161
+195
| +2% | +$23.7K | 0.01% | 260 |
|
|
2025
Q3 | $884K | Buy |
7,966
+92
| +1% | +$10.5K | 0.01% | 273 |
|
|
2025
Q2 | $873K | Buy |
7,874
+392
| +5% | +$41.7K | 0.01% | 267 |
|
|
2025
Q1 | $838K | Sell |
7,482
-1,215
| -14% | -$125K | 0.01% | 271 |
|
|
2024
Q4 | $803K | Buy |
8,697
+5,205
| +149% | +$469K | 0.01% | 279 |
|
|
2024
Q3 | $293K | Sell |
3,492
-29
| -0.8% | -$2.21K | ﹤0.01% | 404 |
|
|
2024
Q2 | $242K | Buy |
3,521
+36
| +1% | +$2.4K | ﹤0.01% | 420 |
|
|
2024
Q1 | $255K | Buy |
3,485
+19
| +0.5% | +$1.46K | ﹤0.01% | 427 |
|
|
2023
Q4 | $281K | Sell |
3,466
-800
| -19% | -$62.3K | ﹤0.01% | 427 |
|
|
2023
Q3 | $320K | Sell |
4,266
-417
| -9% | -$32.1K | 0.01% | 394 |
|
|
2023
Q2 | $361K | Buy |
4,683
+950
| +25% | +$75.8K | 0.01% | 383 |
|
|
2023
Q1 | $308K | Buy |
3,733
+509
| +16% | +$42.2K | 0.01% | 340 |
|
|
2022
Q4 | $277K | Hold |
3,224
| – | – | 0.01% | 348 |
|
|
2022
Q3 | $199K | Sell |
3,224
-163
| -5% | -$10.3K | ﹤0.01% | 375 |
|
|
2022
Q2 | $209K | Buy |
3,387
+150
| +5% | +$9.29K | ﹤0.01% | 364 |
|
|
2022
Q1 | $192K | Sell |
3,237
-300
| -8% | -$19.2K | ﹤0.01% | 393 |
|
|
2021
Q4 | $257K | Sell |
3,537
-1,991
| -36% | -$137K | ﹤0.01% | 367 |
|
|
2021
Q3 | $386K | Sell |
5,528
-1,500
| -21% | -$105K | 0.01% | 277 |
|
|
2021
Q2 | $484K | Sell |
7,028
-2,940
| -29% | -$196K | 0.01% | 264 |
|
|
2021
Q1 | $644K | Sell |
9,968
-2,045
| -17% | -$132K | 0.01% | 234 |
|
|
2020
Q4 | $700K | Sell |
12,013
-177,512
| -94% | -$10.7M | 0.01% | 227 |
|
|
2020
Q3 | $12M | Sell |
189,525
-23,360
| -11% | -$1.62M | 0.28% | 74 |
|
|
2020
Q2 | $16.4M | Sell |
212,885
-20,825
| -9% | -$1.6M | 0.43% | 67 |
|
|
2020
Q1 | $17.5M | Buy |
233,710
+33,572
| +17% | +$2.32M | 0.53% | 56 |
|
|
2019
Q4 | $13M | Sell |
200,138
-33,606
| -14% | -$2.19M | 0.32% | 80 |
|
|
2019
Q3 | $14.8M | Sell |
233,744
-2,910
| -1% | -$190K | 0.39% | 71 |
|
|
2019
Q2 | $16M | Sell |
236,654
-5,086
| -2% | -$335K | 0.6% | 58 |
|
|
2019
Q1 | $15.7M | Buy |
241,740
+29,435
| +14% | +$1.96M | 0.6% | 55 |
|
|
2018
Q4 | $13.3M | Sell |
212,305
-79,563
| -27% | -$5.56M | 0.57% | 56 |
|
|
2018
Q3 | $22.5M | Buy |
291,868
+12
| +0% | +$906 | 0.84% | 44 |
|
|
2018
Q2 | $20.7M | Sell |
291,856
-10,732
| -4% | -$758K | 0.84% | 46 |
|
|
2018
Q1 | $22.8M | Buy |
+302,588
| New | +$24.1M | 0.94% | 44 |
|
Other funds holding GILD
VCM
VPM
Bartlett & Co Wealth Management's GILD Position: Q1 2026 in Review
Bartlett & Co Wealth Management reduced its Gilead Sciences (GILD) stake by 2.1% in Q1 2026, selling an estimated $24.4K and leaving 7,987 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #262.
Bartlett & Co Wealth Management first reported a position in GILD in Q1 2018 and has held it in 33 quarters since. The position peaked at $22.8M in Q1 2018. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Bartlett & Co Wealth Management held 7,987 shares of Gilead Sciences worth $1.06M as of Q1 2026.
- Bartlett & Co Wealth Management sold 174 Gilead Sciences shares in Q1 2026, an estimated $24.4K.
- Gilead Sciences made up 0.01% of Bartlett & Co Wealth Management's portfolio in Q1 2026, its #262 holding.
- Bartlett & Co Wealth Management first reported a position in Gilead Sciences in Q1 2018 and has held it in 33 quarters since.
- Bartlett & Co Wealth Management's Gilead Sciences position peaked at $22.8M in Q1 2018.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Bartlett & Co Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.